Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis.

Publication date: Mar 01, 2024

Concepts Keywords
Covid COVID-19
Indolent COVID-19 Vaccines
Mastocytosis COVID-19 Vaccines
Mrna COVID-19 Vaccines
Vaccine COVID-19/immunology
Humans
Mastocytosis
Mastocytosis, Systemic
Messenger
RNA
RNA, Messenger
RNA, Messenger
Systemic/immunology

Semantics

Type Source Name
disease VO COVID-19 vaccine
disease MESH Indolent Systemic Mastocytosis
disease MESH COVID-19
disease MESH Mastocytosis

Original Article

(Visited 2 times, 1 visits today)